Thailand’s Disease Control Board approves 63-million dose inoculation plan

schedule
2021-02-08 | 13:24h
update
2026-11-07 | 16:47h
person
lasvegasnews.media
domain
lasvegasnews.media


Photo by Thomas SAMSON / POOL / AFP

Thailand’s Disease Control Board has approved the COVID-19 vaccine management and distribution plan for 2021. The country’s health minister, Anutin Charnvirakul, said that Thailand will receive 2 million doses of vaccine from Sinovac soon, and AstraZeneca will deliver another 26 million doses in June. Additionally, Thailand has reserved a further 35 million doses, bringing the total available to 63 million this year.

The first phase of inoculations will begin in February and last until May, with 2 million doses for people in Samut Sakhon’s red zones and nearby provinces, where the number of new cases is still rising, such as Bangkok, Samut Prakan, Nonthaburi, Pathum Thani, Rayong, Chonburi, Chanthaburi, Trat and Tak. The second phase will begin in June and last through December, using another 61 million doses.

Advertisement

Anutin said, Thailand will have limited supplies of vaccines during the first phase, so inoculations of the public will be targeted at critical cases and reducing the fatality rate.

The first groups to receive vaccines will, however, be medical and public health personnel from both the public and private sectors, people with chronic conditions, such as severe respiratory diseases, people with heart conditions, kidney failure, stroke, people undergoing chemo-therapy, diabetics and the morbidly obese.

The inoculations will keep the economy going, strengthen national security and help to build herd immunity. The vaccines will be distributed to the general public, industrial workers, tourism workers and frequent travellers, among others.



Source link

Advertisement

Imprint
Responsible for the content:
lasvegasnews.media
Privacy & Terms of Use:
lasvegasnews.media
Mobile website via:
WordPress AMP Plugin
Last AMPHTML update:
07.11.2026 - 16:47:13
Privacy-Data & cookie usage: